BARTON BREZINA ET AL: "Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications", KIDNEY INTERNATIONAL, vol. 66, no. 90, 1 September 2004 (2004-09-01), pages S39-S45, XP55523207, LONDON, GB ISSN: 0085-2538, DOI: 10.1111/j.1523-1755.2004.09007.x (B1)

DAVID A. BUSHINSKY ET AL: "Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD", CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 13, no. 1, 4 November 2017 (2017-11-04), pages 26-35, XP055625921, ISSN: 1555-9041, DOI: 10.2215/CJN.07300717 (B1)

S. D. NAVANEETHAN ET AL: "Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease", CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 6, no. 10, 1 October 2011 (2011-10-01), pages 2395-2402, XP55330171, ISSN: 1555-9041, DOI: 10.2215/CJN.03730411 (B1)

US-A1- 2002 159 968 (B1)

WO-A2-2008/027551 (B1)

WESSON DONALD E ET AL: "Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension", LANCET, ELSEVIER, AMSTERDAM, NL, vol. 394, no. 10196, 24 June 2019 (2019-06-24), pages 396-406, XP085797718, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(19)31388-1 [retrieved on 2019-06-24] (B1)

WO-A1-2008/103368 (B1)

WO-A2-2005/041902 (B1)

WO-A2-2008/011047 (B1)

US-A1- 2010 189 679 (B1)